MRVI - Maravai Lifesciences Holdings - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart

MRVI is currently covered by 4 analysts with an average price target of $6.6. This is a potential downside of $0.78 (-10.57%) from yesterday's end of day stock price of $7.38.

Maravai Lifesciences Holdings's activity chart (see below) currently has 156 price targets and 111 ratings on display. The stock rating distribution of MRVI is 40% BUY and 60% HOLD.

Stock Analyst Price Targets - Review

Analysts' price targets on this stock were met 61.27% of the time, taking 122.24 days on average.

Highest price target for MRVI is $11, Lowest price target is $3, average price target is $6.6.

Most recent stock forecast was given by PAUL KNIGHT from KEYBANK on 12-Nov-2026. First documented stock forecast 14-Dec-2020.

Best performing analysts who are covering MRVI - Maravai Lifesciences Holdings:

Tejas Savant Paul Knight Erin Wright Daniel Arias Catherine Schulte Dan Brennan

Currently out of the existing stock ratings of MRVI, 2 are a BUY (40%), 3 are a HOLD (60%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 12-Nov-2026

$11

$3.46 (45.89%)

7 days ago
(12-Nov-2026)

4/8 (50%)

$3.3 (42.86%)

72

Hold Since 08-Aug-2024

$8

$0.46 (6.10%)

$11

2 months 10 days ago
(09-Sep-2026)

2/3 (66.67%)

$1.05 (15.11%)

36

Buy Since 15-Dec-2020

$5.5

$-2.04 (-27.06%)

$4.5

6 months 11 days ago
(08-May-2026)

5/6 (83.33%)

$0.65 (13.40%)

122

Hold Since 26-Feb-2026

$3

$-4.54 (-60.21%)

8 months 24 days ago
(26-Feb-2026)

6/11 (54.55%)

$-0.56 (-15.73%)

121

Buy Since 15-Dec-2020

$4

$5

1 years 12 days ago
(07-Nov-2025)

7/14 (50%)

$1.13 (39.37%)

181

Show more analysts

Please expand the browser size to see the chart

What is MRVI (Maravai Lifesciences Holdings) average time for price targets to be met?

On average it took 122 days for the stock forecasts to be reached, with an average price target met ratio of 61.27%.

Which analyst most recently updated their price target on MRVI (Maravai Lifesciences Holdings)?

Paul Knight

Which analyst has the most public recommendations on MRVI (Maravai Lifesciences Holdings)?

Paul Knight works at KEYBANK and has 10 price targets and 10 ratings on MRVI

Which analyst is the currently most bullish on MRVI (Maravai Lifesciences Holdings)?

Erin Wright with the highest potential upside of $46.46

Which analyst is the currently most reserved on MRVI (Maravai Lifesciences Holdings)?

John Sourbeer with the lowest potential downside of -$5.04
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?